Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab—Letter

Daniel A. Goldstein*, Mark J. Ratain

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2435
Number of pages1
JournalClinical Cancer Research
Issue number10
StatePublished - 15 May 2020

Cite this